• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
    • Why Should You Support SAGES?
    • SAGES Swag
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Annual Meeting
      • 2027 Scientific Session Call for Abstracts
      • 2027 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • SAGES Lead Up Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • Innovative Surgical Trends
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Advanced Laparoscopy and Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
    • Foregut Video Atlas
  • Opportunities
    • Join the SAGES Patient Partner Network (PPN)
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs
  • Learning Hub
You are here: Home / Abstracts / NSQIP DATABASE ANALYSIS DOES NOT SUPPORT PREOPERATIVE ANTIBIOTIC USE FOR OUTPATIENT LAPAROSCOPIC CHOLECYSTECTOMY

NSQIP DATABASE ANALYSIS DOES NOT SUPPORT PREOPERATIVE ANTIBIOTIC USE FOR OUTPATIENT LAPAROSCOPIC CHOLECYSTECTOMY

Sora Ely, MD1, Rebecca C Gologorsky, MD1, Michelle R Huyser, MD1, Genna Beattie, MD1, C K Chang, MD2. 1UCSF East Bay Surgery, 2Kaiser Permanente Oakland Medical Center

Introduction: Debate continues regarding utility and safety of routine antibiotic prophylaxis for elective laparoscopic cholecystectomy. Several small, randomized controlled trials have failed to demonstrate benefit, while a handful of larger meta-analyses have reported statistically significant reductions in surgical site infections. However, most of these studies come from clinical settings outside the United States. We used a national database to examine factors associated with postoperative infection in outpatient laparoscopic cholecystectomy.

Methods: We retrospectively reviewed outpatient laparoscopic cholecystectomy cases from the 2015-2016 American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database. Chi-square test and ANOVA were used to identify pre- and intra-operative NSQIP variables associated with postoperative surgical infection, defined as any surgical site, deep wound, or organ space infection.

Results: Postoperative surgical infection occurred in 347 of 41,665 cases (0.8%). Notably, incidence of Clostridium difficile infection in this population was also low (0.2%), but not insignificant by comparison. Furthermore, the majority (91.9%) of C.difficile infections occurred in the absence of a surgical infection.

Factors associated with higher infection rates included: age >89 years, hypertension, congestive heart failure, acute renal failure, dialysis, and chronic steroid use (p<0.05). Strongest predictors of postoperative infection included higher wound classification (p<0.001) and longer operative time (>80 minutes, p<0.001). Infection rates were low in wound classes 1-3, with a marked increase only in class 4 (0.7%, 0.7%, 1.2%, 3.2% respectively).

Using these two clinical variables, we developed a simple scoring system to predict infection risk. Figure 1 shows postoperative infection rates stratified by this score: operating room minutes ≤80 (0) or >80 (1) plus wound class 1-3 (0) or 4 (1).

Conclusions: Risk of postoperative surgical infection after outpatient laparoscopic cholecystectomy is low, and the incidence of C. difficile infection is non-trivial. Although antibiotics may be associated with lower rates of postoperative infection, their marginal clinical benefit in the setting of low absolute risk is tempered by the risk of C. difficile infection, antibiotic resistance, and other adverse effects of antibiotic use.

We recommend against routine antibiotic prophylaxis in low-risk patients undergoing elective, outpatient laparoscopic cholecystectomy. Antibiotics should be considered in cases for which the wound class is 4 and/or the operative time exceeds 80 minutes. Surgeons may wish to utilize this scoring system intra-operatively to inform their decision to administer antibiotics during the case once operative time can be reasonably estimated. A randomized controlled trial is needed to validate this recommendation.


Presented at the SAGES 2017 Annual Meeting in Houston, TX.

Abstract ID: 94892

Program Number: P264

Presentation Session: Poster Session (Non CME)

Presentation Type: Poster

View this Poster

Related



Hours & Info

15821 Ventura Blvd Ste 400
Encino, CA 91436

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2026 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals

Refine Search